Tim F. Greten, M.D.
Medical Oncology Branch and Affiliates
Head, Gastrointestinal Malignancies Section
National Cancer Institute
Building 10 - Magnuson Clinical Center, Room 12N221
10 Center Drive
Bethesda, MD 20892
Dr. Greten received his medical training at Christian Albrechts University in Kiel, Germany in 1993. He did his internship in Munich, followed by a 3-year postdoctoral fellowship at the Johns Hopkins University Baltimore in the laboratory of Drew Pardoll and Liz Jaffee, where he initiated his work in the field of tumor immunology. In 1999, Dr. Greten returned to Hannover Medical School, where he finished his training in internal medicine in 2003, medical oncology in 2004, and gastroenterology in 2007. He held an associate professor position in the Department of Gastroenterology, Hepatology and Endocrinology. In February 2010, he joined CCR's Medical Oncology Branch as the program director of the Gastrointestinal Malignancy Section. Dr. Greten has published more than 70 peer-reviewed papers on basic tumor immunology and translational research studies in hepatocellular carcinoma (HCC), as well as clinical trials in different gastrointestinal malignancies, including HCC. He has also headed the Group for Hepatobiliary Carcinoma from 2006 until 2010, where he coordinated and directed the German Clinical Trial Group (AIO). Currently, Dr. Greten is the chair of the NCI Gastrointestinal Malignancy Faculty and Immunology Faculty..
Dr. Greten's Clinical Trial(s):
NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with digestive/gastrointestinal cancers. Click on the trial(s) below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.